This inventor holds 3 USPTO granted patents. Top assignee: Mitsubishi Kasei Corporation. Active years: 1993-1995.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1993-1995
Title: The Innovations of Yoshihide Nakao
Introduction
Yoshihide Nakao is a prominent inventor based in Machida, Japan. He has made significant contributions to the field of biochemistry, particularly in the development of peptide derivatives that have therapeutic applications. With a total of 3 patents, Nakao's work is recognized for its potential impact on treating various medical conditions.
Latest Patents
Nakao's latest patents focus on parathyroid hormone antagonists, specifically peptide derivatives that exhibit potent inhibitory activity against human parathyroid hormone (hPTH). These derivatives are designed to treat dysbolism associated with calcium or phosphoric acid, including conditions such as hypercalcemia, osteoporosis, hyperparathyroidism, and renal osteodystrophy. The innovative formula includes specific amino acid modifications that enhance the therapeutic efficacy of these compounds.
Career Highlights
Yoshihide Nakao is affiliated with Mitsubishi Kasei Corporation, where he has been instrumental in advancing research in peptide chemistry. His work has not only contributed to the scientific community but has also paved the way for new treatment options in medicine. His dedication to innovation in this field is evident through his patent filings and ongoing research efforts.
Collaborations
Nakao has collaborated with notable colleagues, including Tatsuhiko Kanmera and Akihisa Mori. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the quality of their research.
Conclusion
Yoshihide Nakao's contributions to the field of biochemistry through his innovative patents highlight the importance of research in developing new therapeutic agents. His work continues to inspire advancements in medical treatments and showcases the potential of peptide derivatives in addressing critical health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile